From acne to chronic pain relief, the market for transdermal patches is growing. Lounge explores the science, and reasons for ...

In today’s fast-paced world, staying healthy can often feel like an uphill battle. With our daily responsibilities and hectic ...

Benchmark analyst Robert Wasserman maintained a Buy rating on Immunoprecise Antibodies Ltd. (NASDAQ:IPA) with a price target ...

Immunoprecise shares closed higher on Wednesday after the company announced it developed a new class of GLP-1 therapies.

ORLANDO, Fla., Dec. 31, 2024 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders highlighting the ...

AVERSA™ Fentanyl Advances Toward Commercialization Our lead product, AVERSA™ Fentanyl, is poised to become the world’s first abuse-deterrent opioid transdermal patch. We made significant ...